Telix Pharmaceuticals Limited
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $141.9M | $440.0M | $84.3M |
| Accounts Receivable | $129.2M | $86.9M | $44.0M |
| Inventory | $37.1M | $23.6M | $12.7M |
| Total Current Assets | $330.3M | $570.1M | $158.7M |
| Property, Plant & Equipment | — | — | — |
| Goodwill | $199.0M | $66.6M | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $1.16B | $940.4M | $277.3M |
| Liabilities | |||
| Accounts Payable | $150.3M | $86.8M | $54.3M |
| Total Current Liabilities | $231.6M | $205.1M | $111.4M |
| Long-Term Debt | $391.9M | $341.8M | $5.9M |
| Total Liabilities | $748.6M | $587.4M | $174.6M |
| Stockholders' Equity | |||
| Retained Earnings | $-154.5M | $-152.9M | $-187.1M |
| Total Stockholders' Equity | $415.4M | $352.9M | $102.6M |